You searched for metabolic diseases - Page 25 of 63

In Depth 9 Jun 2023

Enhancing canine wellness: The promise of immunotherapy for dogs

…treat allergic diseases in dogs has been around for several decades now, but there has been a surge of interest and research aimed at harnessing the power of the immune…

June 9, 2023 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 13 Jun 2024

Eight companies tackling cancer with allogeneic cell therapy in 2024

…as cancer, cardiovascular diseases, autoimmune disorders, and genetic diseases. The market size was valued at $255.6 million in 2022, and is expected to grow at a compound annual growth rate…

June 13, 2024 - 9 minutesmins - By Jules Adam

In Depth 24 Jan 2024

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

Cell therapy has drastically improved the scope of treatment for a number of diseases in the last few years. Now, engineered B cells are the latest approach in the field…

January 24, 2024 - 7 minutesmins - By Willow Shah-Neville

More News! 11 Sep 2017

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

…is found in animals and humans too, could help to overcome age-related diseases. During the study, yeast cells were exposed to different stress conditions and lifespan, protein synthesis and Gcn4…

September 11, 2017 - 2 minutesmins - By Alex Dale

Interview 25 Apr 2019

European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?

…there still room for more development in this somewhat crowded area? Eric Tauber, CEO of Themis Bioscience, an Austrian biotech that focuses on vaccines for infectious diseases and cancer, believes…

April 25, 2019 - 11 minutesmins - By Helen Albert

News and Trends 4 Aug 2022

Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx

A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory disorders and cancer has been bought by biopharmaceutical company, Amgen for $52 per share. ChemoCentryx…

August 4, 2022 - 3 minutesmins - By Liza Laws

News and Trends 11 Nov 2022

Prurigo nodularis treatment recommended for EU approval

…often co-morbid diseases. These diseases include approved indications for Dupixent, such as atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP), as well as investigational diseases prurigo nodularis and…

November 11, 2022 - 3 minutesmins - By Jim Cornall

Expert Advice 7 Aug 2019

Why Making the Jump from Pharma to Biotech Can be a Life Changing Experience

…and focused on rare diseases. There are 7,000 rare diseases that affect 60 million people in Europe and the United States, but only 5% have treatments today. These often affect…

August 7, 2019 - 13 minutesmins - By Helen Albert

News and Trends 28 Mar 2017

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?

…innings compared to oncology treatments, and it’s primarily targeting rare and orphan diseases. The model for these diseases is very different with pharma.” Frédéric Revah, CEO of Généthon, was more…

March 28, 2017 - 5 minutesmins - By Evelyn Warner

gsk morphosys hand osteoarthritis rheumatoid

News and Trends 19 Apr 2016

GSK goes to phase II with German Antibody for Inflammatory Diseases

…a treatment for rheumatoid arthritis. Like most auto-immune inflammatory diseases, this is a much coveted indication for its blockbuster potential. GSK has previously sold a multiple sclerosis drug to Novartis…

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

biorelate artificial intelligence cell gene therapy

Startup Scout 25 Oct 2019

This UK AI Tool Researches Diseases for Drug Discovery Companies

…Healx, which recently raised €51M to fund the development of technology for identifying repurposed drugs for rare diseases. “We really like Healx here at Biorelate and think the company has…

October 25, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 30 Nov 2022

bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases

…of the brain’s electrical signals. This function is essential for information to be efficiently relayed throughout the brain. GABAergic neuron dysfunction has been associated with a variety of neurological diseases,…

November 30, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Enhancing canine wellness: The promise of immunotherapy for dogs

Eight companies tackling cancer with allogeneic cell therapy in 2024

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?

Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx

Prurigo nodularis treatment recommended for EU approval

Why Making the Jump from Pharma to Biotech Can be a Life Changing Experience

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?

GSK goes to phase II with German Antibody for Inflammatory Diseases

This UK AI Tool Researches Diseases for Drug Discovery Companies

bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!